• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者大脑中的氧化代谢缺陷。

Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease.

作者信息

Hoyer S

机构信息

Institut for Patochemie und Allgemeine Neurochemie, Ruprecht-Karis Universitat, Heidelberg, Germany.

出版信息

Acta Neurol Scand Suppl. 1996;165:18-24. doi: 10.1111/j.1600-0404.1996.tb05868.x.

DOI:10.1111/j.1600-0404.1996.tb05868.x
PMID:8740985
Abstract

Glucose metabolism in the brain has an important influence on many normal cellular processes. It contributes to the synthesis of acetylcholine, glutamate, aspartate, gamma-aminobutyric acid, glycine, and ATP production (the driving force behind almost all cellular and molecular activity). Neuronal glucose metabolism is controlled antagonistically by insulin and cortisol. Desensitization of the neuronal insulin receptor causes abnormalities in oxidative energy metabolism. During normal aging, the cerebral energy pool is slightly diminished, but its level increases after stressful events. In age-related sporadic late-onset dementia of the Alzheimer type (SDAT), glucose metabolism and formation of cellular energy are severely reduced. Desensitization of the neuronal insulin receptor seems to be an early event in the pathogenesis or even etiology of SDAT causing disturbances in oxidative glucose metabolism and energy failure in insulin-sensitive brain structures. These abnormalities appear to induce a cascade of disturbances that leads to abnormal APP processing and amyloid formation, membrane damage, and neuronal death.

摘要

大脑中的葡萄糖代谢对许多正常细胞过程具有重要影响。它有助于乙酰胆碱、谷氨酸、天冬氨酸、γ-氨基丁酸、甘氨酸的合成以及ATP的产生(几乎所有细胞和分子活动背后的驱动力)。神经元葡萄糖代谢受胰岛素和皮质醇的拮抗控制。神经元胰岛素受体的脱敏会导致氧化能量代谢异常。在正常衰老过程中,大脑能量储备会略有减少,但在应激事件后其水平会升高。在与年龄相关的散发性晚发性阿尔茨海默型痴呆(SDAT)中,葡萄糖代谢和细胞能量形成会严重减少。神经元胰岛素受体的脱敏似乎是SDAT发病机制甚至病因中的早期事件,会导致胰岛素敏感脑结构中的氧化葡萄糖代谢紊乱和能量衰竭。这些异常似乎会引发一系列紊乱,导致异常的APP加工和淀粉样蛋白形成、膜损伤以及神经元死亡。

相似文献

1
Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease.阿尔茨海默病患者大脑中的氧化代谢缺陷。
Acta Neurol Scand Suppl. 1996;165:18-24. doi: 10.1111/j.1600-0404.1996.tb05868.x.
2
Models of Alzheimer's disease: cellular and molecular aspects.阿尔茨海默病模型:细胞与分子层面
J Neural Transm Suppl. 1997;49:11-21. doi: 10.1007/978-3-7091-6844-8_2.
3
Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)?神经元胰岛素受体脱敏:阿尔茨海默型迟发性散发性痴呆(SDAT)病因发病机制的一种新方法?
Arch Gerontol Geriatr. 1995 Jul-Aug;21(1):63-74. doi: 10.1016/0167-4943(95)00646-3.
4
Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism.衰老过程中阿尔茨海默病的风险因素。葡萄糖/能量代谢的影响。
J Neural Transm Suppl. 1998;54:187-94. doi: 10.1007/978-3-7091-7508-8_18.
5
Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update.散发性阿尔茨海默病中的脑葡萄糖与能量代谢异常。病因与后果:最新进展
Exp Gerontol. 2000 Dec;35(9-10):1363-72. doi: 10.1016/s0531-5565(00)00156-x.
6
Age-related changes in cerebral oxidative metabolism. Implications for drug therapy.大脑氧化代谢的年龄相关变化。对药物治疗的影响。
Drugs Aging. 1995 Mar;6(3):210-8. doi: 10.2165/00002512-199506030-00004.
7
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.阿尔茨海默病中的葡萄糖代谢与胰岛素受体信号转导
Eur J Pharmacol. 2004 Apr 19;490(1-3):115-25. doi: 10.1016/j.ejphar.2004.02.049.
8
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.衰老与散发性阿尔茨海默病中的脑胰岛素及胰岛素受体
J Neural Transm (Vienna). 1998;105(4-5):423-38. doi: 10.1007/s007020050068.
9
Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease.脑葡萄糖代谢变化是阿尔茨海默病发病机制的关键。
Gerontology. 1994;40(5):246-52. doi: 10.1159/000213592.
10
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.从紊乱的大脑葡萄糖代谢解码阿尔茨海默病:对诊断和治疗策略的影响。
Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11.

引用本文的文献

1
Protective Effect of Flavonoids against Methylglyoxal-Induced Oxidative Stress in PC-12 Neuroblastoma Cells and Its Structure-Activity Relationships.黄酮类化合物对甲基乙二醛诱导的 PC-12 神经母细胞瘤细胞氧化应激的保护作用及其构效关系。
Molecules. 2022 Nov 12;27(22):7804. doi: 10.3390/molecules27227804.
2
Disentangling Mitochondria in Alzheimer's Disease.解析阿尔茨海默病中的线粒体。
Int J Mol Sci. 2021 Oct 26;22(21):11520. doi: 10.3390/ijms222111520.
3
Amyloids: The History of Toxicity and Functionality.淀粉样蛋白:毒性与功能性的历史
Biology (Basel). 2021 May 1;10(5):394. doi: 10.3390/biology10050394.
4
Tetrahydrocannabinol-Rich Extracts From L. Improve Glucose Consumption and Modulate Metabolic Complications Linked to Neurodegenerative Diseases in Isolated Rat Brains.来自[植物名称未给出]的富含四氢大麻酚的提取物可改善分离的大鼠大脑中的葡萄糖消耗,并调节与神经退行性疾病相关的代谢并发症。
Front Pharmacol. 2020 Nov 24;11:592981. doi: 10.3389/fphar.2020.592981. eCollection 2020.
5
Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality.非甾体抗炎药在老年人中的使用降低了阿尔茨海默病死亡率。
PLoS One. 2019 Sep 17;14(9):e0222505. doi: 10.1371/journal.pone.0222505. eCollection 2019.
6
The "great" controlling nucleotide coenzymes.“伟大的”调控核苷酸辅酶。
IUBMB Life. 2019 May;71(5):565-579. doi: 10.1002/iub.1997. Epub 2019 Jan 9.
7
Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).计算建模与生物标志物研究在阿尔茨海默病药物治疗中的应用(综述)。
Mol Med Rep. 2018 Jul;18(1):639-655. doi: 10.3892/mmr.2018.9044. Epub 2018 May 22.
8
Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.红细胞代谢异常作为阿尔茨海默病的一个风险因素
Front Neurosci. 2018 Jan 5;11:728. doi: 10.3389/fnins.2017.00728. eCollection 2017.
9
Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach.确定非甾体抗炎药对阿尔茨海默病保护作用的分子途径:一种生物信息学方法。
Comput Struct Biotechnol J. 2016 Oct 29;15:1-7. doi: 10.1016/j.csbj.2016.10.003. eCollection 2017.
10
Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.在散发性阿尔茨海默病实验模型中,T3D-959改善脑胰岛素/胰岛素样生长因子信号传导并减轻神经炎症。
J Alzheimers Dis. 2017;55(2):849-864. doi: 10.3233/JAD-160656.